MoonLake Immunotherapeutics (MLTX)
12.51
-0.67
(-5.08%)
USD |
NASDAQ |
Sep 11, 16:00
12.59
+0.08
(+0.64%)
After-Hours: 20:00
MoonLake Immunotherapeutics Market Cap : 1.046B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.046B |
| September 10, 2026 | 1.102B |
| September 09, 2026 | 1.147B |
| September 08, 2026 | 1.249B |
| September 04, 2026 | 1.255B |
| September 03, 2026 | 1.270B |
| September 02, 2026 | 1.259B |
| September 01, 2026 | 1.265B |
| August 31, 2026 | 1.258B |
| August 28, 2026 | 1.253B |
| August 27, 2026 | 1.298B |
| August 26, 2026 | 1.306B |
| August 25, 2026 | 1.301B |
| August 24, 2026 | 1.285B |
| August 21, 2026 | 1.318B |
| August 20, 2026 | 1.327B |
| August 19, 2026 | 1.400B |
| August 18, 2026 | 1.366B |
| August 17, 2026 | 1.367B |
| August 14, 2026 | 1.377B |
| August 13, 2026 | 1.380B |
| August 12, 2026 | 1.441B |
| August 11, 2026 | 1.387B |
| August 10, 2026 | 1.449B |
| August 07, 2026 | 1.527B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.507B |
| August 05, 2026 | 1.467B |
| August 04, 2026 | 1.293B |
| August 03, 2026 | 1.255B |
| July 31, 2026 | 1.330B |
| July 30, 2026 | 1.370B |
| July 29, 2026 | 1.326B |
| July 28, 2026 | 1.350B |
| July 27, 2026 | 1.434B |
| July 24, 2026 | 1.372B |
| July 23, 2026 | 1.397B |
| July 22, 2026 | 1.366B |
| July 21, 2026 | 1.447B |
| July 20, 2026 | 1.374B |
| July 17, 2026 | 1.420B |
| July 16, 2026 | 1.371B |
| July 15, 2026 | 1.440B |
| July 14, 2026 | 1.408B |
| July 13, 2026 | 1.472B |
| July 10, 2026 | 1.469B |
| July 09, 2026 | 1.438B |
| July 08, 2026 | 1.376B |
| July 07, 2026 | 1.381B |
| July 06, 2026 | 1.362B |
| July 02, 2026 | 1.367B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Basilea Pharmaceutica AG | 959.99M |
| Santhera Pharmaceuticals Holding AG | 265.06M |
| BeOne Medicines Ltd. | 36.10B |
| AC Immune SA | 251.43M |
| CRISPR Therapeutics AG | 4.999B |
Market Cap Related Metrics
| PEG Ratio | -0.087 |
| Price to Book Value | 2.443 |
| Price | 12.51 |
| Earnings Yield | -30.66% |
| PEGY Ratio | -0.087 |